| Product NDC: | 43063-367 |
| Proprietary Name: | Alprazolam |
| Non Proprietary Name: | Alprazolam |
| Active Ingredient(s): | .5 mg/1 & nbsp; Alprazolam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-367 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074174 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070328 |
| Package NDC: | 43063-367-98 |
| Package Description: | 120 TABLET in 1 BOTTLE, PLASTIC (43063-367-98) |
| NDC Code | 43063-367-98 |
| Proprietary Name | Alprazolam |
| Package Description | 120 TABLET in 1 BOTTLE, PLASTIC (43063-367-98) |
| Product NDC | 43063-367 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alprazolam |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070328 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ALPRAZOLAM |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |